U.S. employers step up efforts to manage the high cost of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
U.S. employers step up efforts to manage the high cost of prescription drugs

ARLINGTON, Va., Nov. 03, 2016 (GLOBE NEWSWIRE) -- With no end in sight to rising prescription drug prices, U.S. employers are stepping up efforts to manage costs while continuing to ensure employees have access to the drugs they need, according to the 21st annual Best Practices in Health Care Employer Survey by Willis Towers Watson (NASDAQ: WLTW ). Employers are paying particular attention to high-cost specialty medications used to treat complex conditions such as cancer and hepatitis C. For example, the cost of new and highly effective prescription drugs or combinations of drugs for treating hepatitis C ranges from $65,000 to $120,000 for a three-month course of treatment.

“High price tags for specialty drugs are the main driver of employers more carefully examining their spending on pharmaceuticals and how they manage their employee pharmacy benefit programs,” said Nadina Rosier, North American Pharmacy practice leader for Willis Towers Watson. “But employers also are motivated because prescription drugs overall account for about 25% of the total cost of employer-sponsored medical benefits and an even larger percentage of growth in the cost of medical benefits. Failure to act now could cost employers hundreds of millions of dollars over the next few years and for the foreseeable future.” Previously released survey results found that nearly nine in 10 employers have identified managing pharmacy spending as their top priority over the next three years. Common strategies employers are using today include:

  • Evaluating and renegotiating pharmacy contracts to obtain better pricing. Today, 63% of employers do this; another 31% are planning or considering this by 2018.
  • Ensuring appropriate utilization. Today, 61% of employers have added programs to ensure appropriate use of prescription drugs, up from 53% in 2015; 85% are considering doing so by 2018.
  • Restricting or excluding the use of certain drugs when equally effective, lower-cost alternatives are available. For example, 52% of employers exclude compound drugs; another 13% are considering this action by 2018.

With regard to specialty drugs, strategies growing in popularity include:

  • Evaluating specialty drug spend through the medical benefit instead of the pharmacy benefit. Today, 39% of employers have adopted this strategy, up from 26% in 2015; 82% will consider it by 2018.
  • Making changes to coverage to influence where and how specialty drugs are administered. Today, 19% of employers have made such changes; another 43% are considering them for 2018.
  • Establishing different copays for specialty drugs to promote the use of lower-cost alternatives such as biosimilars. Today, 18% of employers have done this, a number that could triple over the next two years.

“Companies tend to adopt simple solutions that result in a financial benefit first and move on to more complicated strategies later,” said Rosier. “Our survey shows that employers are rapidly becoming more aggressive, for example, by evaluating specialty pharmacy spend through the medical benefit to get more visibility into where these drugs are being administered. This is an essential component of managing specialty pharmacy spend, but it is just the beginning. Employers still need to take action based on what they learn.”

A bout the survey

The annual Willis Towers Watson Best Practices in Health Care Employer Survey was completed by 600 U.S. employers between June and July 2016 and reflects respondents’ 2016 health program decisions and strategies, and in some cases, their 2017 and 2018 plans. Respondents collectively employ 12.2 million full-time employees and operate in all major industry sectors.

About Willis Towers Watson

Willis Towers Watson (NASDAQ: WLTW ) is a leading global advisory, broking and solutions company that helps clients around the world turn risk into a path for growth. With roots dating to 1828, Willis Towers Watson has 39,000 employees in more than 120 countries. We design and deliver solutions that manage risk, optimize benefits, cultivate talent and expand the power of capital to protect and strengthen institutions and individuals. Our unique perspective allows us to see the critical intersections between talent, assets and ideas — the dynamic formula that drives business performance. Together, we unlock potential. Learn more at willistowerswatson.com .

Media contact Rob Wyse: +1 212 920 1470 rob@capital-content.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
A Faded Sign Is a Quiet Leak in Storefront Demand Today

Updated Category News Views 95

Sunlight does not care what the marketing budget said. A storefront can have a decent product, a clean interior and a capable crew, then lose the first impression before anyone reaches the door because its sign looks tired. That is the plainspoken point behind FASTSIGNS' latest guidance on outdoor sign lifespan. This is not glamorous stuff, but it is operationally...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 25

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Abacus Global Faces Scrutiny Over Accounting Practices

Updated Category News Views 128

Storm Clouds Gather over Abacus Global Management If it ain't one thing, it's another—at least that's what folks holding the bag with Abacus Global (ABX) are thinking right now. News of a pending investigation has dropped like a lead balloon, and the air is thick with scrutiny over their financial dealings. We're jawing about related-party transactions now under the...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 60

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 20

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 27

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 186

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 84

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading

Top 5 Most Recently Viewed Articles

Growing FPSO Market Set to Reach $174 Billion by 2031

Updated Category News Views 101

Insights into the Floating Production Storage Offloading Market The Floating Production Storage Offloading (FPSO) market is emerging as a cornerstone in the offshore oil and gas industry. As global oil demands continue to escalate, industries and stakeholders are directing their attention towards FPSO technologies, which combine production and storage capabilities to...

Continue Reading
3D Systems Corporation Faces Potential Securities Fraud Lawsuit

Updated Category News Views 207

Potential Securities Fraud Lawsuit Against 3D Systems Corporation Investors in 3D Systems Corporation have a significant opportunity as rumors of a securities fraud lawsuit surface. This potential lawsuit is connected to claims of misleading statements made by the company regarding its financial performance and market outlook. Overview of the Allegations According to...

Continue Reading
Latest Insights into the U.S. Real Estate Landscape Today

Updated Category News Views 368

Understanding Recent Trends in U.S. Real Estate In recent months, the real estate market in the United States has demonstrated some fascinating trends. Notably, many Americans are choosing to stay in their homes rather than moving. In fact, only 11% moved in a recent year, a stark contrast to historical figures where up to a third of the population changed residences...

Continue Reading
Venture Global, Inc. Investors Encouraged to Take Action Soon

Updated Category News Views 285

Important Deadlines for Venture Global, Inc. Investors Investors of Venture Global, Inc. should pay close attention to approaching deadlines related to an ongoing securities class action. Those who purchased stock pursuant to the company's initial public offering (IPO) that took place in early 2025 have significant rights that might not require any out-of-pocket expense....

Continue Reading
Vatn Systems Makes Strategic Acquisition to Boost AUV Tech

Updated Category News Views 160

Vatn Systems' Strategic Move to Enhance Underwater Technology In an exciting development for the defense technology sector, Vatn Systems has made a significant advancement by acquiring Crewless Marine. This decision is part of Vatn's strategy to improve its autonomous underwater vehicles (AUVs), highlighting the importance of acoustic capabilities in undersea warfare....

Continue Reading